Novavax (NVAX) Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Novavax (NVAX) Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination

Novavax (NVAX) Misses Q2 EPS by $1.12

August 5, 2021 4:31 PM EDT

Novavax (NASDAQ: NVAX) reported Q2 EPS of ($4.75), $1.12 worse than the analyst estimate of ($3.63). Revenue for the quarter came in at $298 million versus the consensus estimate of $387.87 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

... More